Hindu (Free subscription) | 08/19/2008
MUMBAI: Lupin has entered into a multi-year promotion and marketing agreement for the AeroChamber Plus line of products with Forest Laboratories of the U.S. Under the agreement, Lupin Pharmaceuticals of the U.S will use its 50 person sales ...
World of stocks (Free subscription) | 08/16/2008
TheStreet.com Winners & Losers Tech Winners & Losers: Cypress Semiconductor Financial Winners & Losers: Ambac 8/15/2008 5:47 PM EDT Health Winners & Losers: Forest Labs 8/15/2008 5:26 PM EDT Technical Outlook: Watch for New Leaders 8/15/2008 4:13 PM EDT Best Fixed-Income Funds Rode Dollar Woes July's top performers benefited from weakness in the greenback, but these funds could be hurt...
The Street (Free subscription) | 08/15/2008
Health stocks were mixed going into the weekend with light news. Pharma stocks ended Friday barely into the black. The Amex Pharmaceutical Index edged up 2.28, or 0.7%, to 317.83. All of its components except AstraZenecaAZN and GlaxoSmithKlineGSK managed to end the day in positive territory. Those stocks lost 40 cents and 25 cents, respectively. The best performer on the pharma index was Forest...
Reuters (Free subscription) | 07/22/2008
NEW YORK (Reuters) - Forest Laboratories Inc reported a 9 percent decline in quarterly profit on Tuesday on higher sales and administrative costs, but results were better than expected and the company forecast fiscal-year earnings ahead of analyst projections.
Market Watch (Free subscription) | 07/22/2008
NEW YORK (MarketWatch) -- Forest Laboratories Inc. said Tuesday that it earned $242.9 million, or 79 cents a share, in its first quarter, down from $268.2 million, or 83 cents a share, in the year-earlier period. The latest results included a charge of 8 cents a share, related to a terminated co-promotion agreement with Daiichi Sankyo. The New York pharmaceutical company said revenue for the...
The Earth Times Online Newspaper (Free subscription) | 07/22/2008
NEW YORK (Reuters) - Forest Laboratories Inc reported a 9 percent decline in quarterly profit on Tuesday on higher sales and administrative costs, but results were better than expected and the company forecast fiscal-year earnings ahead of analyst projections.
Seeking Alpha (Free subscription) | 08/21/2008
Davy Bui submits: In their 13F-HR filing for Q2 2008 , Bruce Berkowitz and his cohorts at the Fairholme Fund continue their shift from energy into healthcare: Fairholme opened huge (relative) positions in Pfizer (PFE), Forest Labs (FRX) and UnitedHealth Group (UNH). The UNH position echos Seth Klarman’s endorsement. I don’t follow the pharma industry too closely but it seems as if Berkowitz...
The Street (Free subscription) | 08/14/2008
Notable option trading in Autodesk, Knight Capital, Forest Labs and more.
Smart Money (Free subscription) | 08/08/2008
Edward Owens, who has run Vanguard Health Care since its debut 24 years ago, is heavily weighted in Big Pharma stocks right now. The fund's top three holdings are Schering-Plough), Eli Lilly) and Forest Labs). Owens also invests in biotechs and a range of other health-related companies, from drug distributors to managed-care providers. Lipper gives the fund its highest rating (five stars)...
PR News Wire (Free subscription) | 07/24/2008
... Insulet Corporation (PODD), LifeCell (sold to KCI), Given Imaging (GIVN), Cerexa (sold to Forest Labs), Peninsula Pharmaceuticals (sold to Johnson & Johnson), Predix (sold to EPIX), Avanir (AVNR), Orthovita (VITA), Auxillium (AUXL), Bioenvision (sold to Genzyme), Adiana (sold to Cytyc), and Emphasys Medical. Mr. Silverstein has a B.A. in Economics from Denison University and a J.D....
The Street (Free subscription) | 07/10/2008
... On Tuesday -- a day when the market rallied -- we picked up two wins with Sanofi-Aventis and Forest Labs. Combined, they brought in $7,300 in profit. Both required us to average down, adding to our positions as the stock price of these picks declined. While many others were likely wincing at all the blood in the streets on Wednesday, those who follow my picks had something to cheer...
